Chargement en cours...
Therapeutic advances in the management of Pompe disease and other metabolic myopathies
The world of metabolic myopathies has been dramatically modified by the advent of enzyme replacement therapy (ERT), the first causative treatment for glycogenosis type II (GSDII) or Pompe disease, which has given new impetus to research into that disease and also other pathologies. This article revi...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3755530/ https://ncbi.nlm.nih.gov/pubmed/23997816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285613487570 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|